Biomarker for acute wheezing exacerbation in preschool wheeze
- Conditions
- o
- Registration Number
- TCTR20200310002
- Lead Sponsor
- research fund and deta analysis unit, Faculty of Medicine Ramathibodi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 120
asthma group : Children aged 2-5 years who had a diagnosis of asthma (include AD,AR) by GINA guideline 2018
Viral induced wheezing group :Children aged 2-5 years recurrent wheezing ≥ 2 episodes confirmed by physician
control group :Healthy children aged 2-5 years
no underlying disease
asthma group :Post respiratory tract infection in 4 week
Coexisting disease :
Malignancy
Active autoimmune disease
HIV infection
Cardiovascular diseases
Immunodeficiency Chronic lung disease
-Inhaled corticosteroid use in 4 week
Viral induced wheezing group :Post respiratory tract infection in 4 week
Coexisting disease :
Malignancy
Active autoimmune disease
HIV infection
Cardiovascular diseases
Immunodeficiency Chronic lung disease
-Inhaled corticosteroid use in 4 week
-allergen sensitization
control group :Post respiratory tract infection in 4 week
history allergen sensitization and atopy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method serum periostin 1 year regression analysis
- Secondary Outcome Measures
Name Time Method eosinophil cationic protein 1 year ANOVA